openPR Logo
Press release

Chemiluminescence Immunoassay (CLIA) Analyzers Market to Grow at CAGR of 6.0% through 2025

04-10-2018 03:08 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Chemiluminescence Immunoassay (CLIA) Analyzers Market to Grow

The global chemiluminescence immunoassay (CLIA) analyzers market was valued over US$ 4.4 Bn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 6.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Chemiluminescence Immunoassay (CLIA) Analyzers Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising demand for international accreditations and result comparability by using high-throughput automated immunoassays is spurring the growth of chemiluminescence immunoassay (CLIA) analyzers in coming years (2017 to 2025).

The North America and Europe are projected to dominate the global chemiluminescence immunoassay (CLIA) analyzers market in the coming years owing to increase in manufacturer focus for business expansion in these regions. Players are continuously developing multiplexed assay platforms and entering into distribution agreements to fortify their footprints in the North American and European markets. Growing adoption of technologically advanced products manufactured by local manufacturers like Shenzhen New Industries Biomedical Engineering Co., Ltd. is likely to drive the Asia Pacific chemiluminescence immunoassay (CLIA) analyzers market. The Asia Pacific chemiluminescence immunoassay (CLIA) analyzers market is expected to witness CAGR of over 6.5% from 2017 to 2025.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31517

Reagents Dominates the Market Followed by Automated Analyzers

The report offers detailed segmentation of global chemiluminescence immunoassay (CLIA) analyzers market based on product, application, and end-user. Among the product segment, reagents segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Factors attributed to the higher share of the reagent segment in the global market include frequent replacements leading to increasing usage of reagents when compared to analyzer platforms. Automated analyzers segment is likely to register comparatively higher growth rate in terms of value in the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period owing to continuous innovations in the product technologies by major market players.

Endocrine Disorders & Oncology: Top Two Application Areas of Chemiluminescence Immunoassay (CLIA) Analyzers

Among applications, endocrine disorders segment is projected to hold dominant share of global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period and is likely to expand at CAGR more than 6.0% from 2017 to 2025. Major factors responsible for the dominance of this segment are continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers. For instance, in January, 2017, the world's first assay to measure free vitamin D was introduced by Future Diagnostics Solutions and DIAsource Immunoassays SA (Anteo Group).

Such continuous new product launches, along with exponentially rising patient base in developed as well as developing countries are likely to drive the segment between 2017 and 2025. According to the National Institute of Diabetes & Digestive and Kidney Diseases in the U.S., nearly 4.6% of the U.S. population suffers from hypothyroidism, which highlights the significant need for advanced testing methods to diagnose the endocrine disorder. Hepatitis and retrovirus segment, accounted for more than 10.0% share of global chemiluminescence immunoassay (CLIA) analyzers market in 2016, in terms of value. It is anticipated to have substantial growth and account for approximately 12.0% of market share by 2025.

Growth of the Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Likely To Be Hinged At China, India

In terms of value, North America is likely to continue its dominance in the global chemiluminescence immunoassay (CLIA) analyzers market throughout the forecast period, owing to significant average selling prices of automated chemiluminescence immunoassay analyzers, rising demand from physicians for technologically advanced diagnostic instruments with enhanced specificity and precision, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region. Latin America and Middle East & Africa are relatively untapped markets having high growth potential.

The governmental cap on prices of analyzers and group purchasing policies by major multispecialty hospital chains in this region is further increasing adoption of rental CLIA analyzers in these regions. Middle East & Africa chemiluminescence immunoassay (CLIA) analyzers market is characterized with significant population base demanding affordable care, and rise in governmental initiatives for early diagnosis of these chronic diseases. For instance, as per UNAIDS publication in 2016, nearly 65% of the world’s HIV infected population are present in this region.

Request for TOC @ https://www.transparencymarketresearch.com/report-toc/31517

Highly Consolidated Market With Top Three Players Accounting For More Than 50.0% of the Global Market

The report also provide profiles of leading players operating in global chemiluminescence immunoassay (CLIA) analyzers market. F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, and Beckman Coulter, Inc. (Danaher) are major players operating in the market, offering products with proprietary technologies, such as F. Hoffmann-La Roche Ltd.’s products are manufactured using proprietary electrochemiluminescence technology, while Abbott’s CLIA analyzers are manufactured using the chemiluminescent microparticle immunoassay technology. DiaSorin S.p.A. and Shenzhen New Industries Biomedical Engineering Co., Ltd. are the other major players in the developed and developing countries, respectively.

Obtain Report Details @ https://www.transparencymarketresearch.com/chemiluminescence-immunoassay-analyzers-market.html

Expansion of tests offering in integrated digital diagnostics platform through partnerships to improve oncology and critical care treatment is a growing trend in global chemiluminescence immunoassay (CLIA) analyzers market. For instance, in January 2018, F. Hoffmann-La Roche Ltd. and GE Healthcare entered into strategic partnership to develop an industry-first digital platform, which will provide digital clinical decision support solutions in oncology and critical care treatment. Other prominent players in the global chemiluminescence immunoassay (CLIA) analyzers market include Sysmex Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics (a part of Carlyle Group), and Tosoh Corporation.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemiluminescence Immunoassay (CLIA) Analyzers Market to Grow at CAGR of 6.0% through 2025 here

News-ID: 1010152 • Views: 202

More Releases from Transparency Market Research

Teledentistry Market Analysis and Demand With Forecast Overview to 2030
Global Teledentistry Market – Overview Teledentistry is a kind of telehealth that deals with using information technology and telecommunications for providing dental care, public awareness, consultation, and education. Teledentistry has the ability to address many of the problems related to cost efficiency, access, and quality of dental care. Read Report Overview - https://www.transparencymarketresearch.com/teledentistry-market.html It can also give care to the underserved users, such as those in remote areas at a manageable cost through
Infusion Rate Monitoring Market Expected to Witness the Highest Growth 2030
Global Infusion Rate Monitoring Market: Snapshot The global infusion rate monitoring market is foreseen to gather exceptional sales opportunities during the forecast period of 2020 to 2030. Infusion rate monitoring is a technique that is gaining traction in worldwide healthcare sector owing to a wide range of advantages it offers. Veterinary infusion rate monitor and human infusion rate monitor are the product types available in the market for infusion rate monitoring. Read
Blood Lactate Analyzer Market Share, Trends, Business Strategy and Forecast to 2 …
Due to the rising incidence of major chronic illnesses such as hyperthermia, trauma, anemia, diabetes, and others, the global blood lactate analyzer market is expected to expand at a rapid pace. As a result of these illnesses, which lead to a rise in the levels of blood lactate, the need for lactate analyzers has increased. Augmented awareness about exercise or physical training, which leads to a rise in demand for
Hospital Asset Tracking Systems Market to Experience Significant Growth During t …
Global Hospital Asset Tracking and Inventory Management Systems Market: Overview The demand within the global market for hospital asset tracking and inventory management systems has been rising on account of commercialisation of the healthcare industry. The profitability of the healthcare business has led several entities to invest in this domain. Read Report Overview - https://www.transparencymarketresearch.com/hospital-asset-tracking-and-inventory-management-systems-market.html It is extremely important to track the assets pertaining to the healthcare sector, and this factor has given

All 5 Releases


More Releases for CLIA

04-21-2021 | Health & Medicine
Fact.MR
Key End-use Industries to Surge Sales of Chemiluminescence Immunoassay (CLIA) An …
Laboratories across the world are increasingly adopting chemiluminescence immunoassay (CLIA) technology to label antibodies. Chemiluminescent methods serve as important tools in biomedical research. The number of clinical tests incorporating CLIA techniques is forecast to be leveraged, attributed to technological breakthroughs in disease diagnostics and rise in demand for preventive diagnostics and treatment monitoring. Click HERE to Get Complete Synopsis of the Report- https://www.factmr.com/report/4734/chemilumine scence-immunoassay-clia-analyzers-market On the back of these trends, the global Chemiluminescence
Chemiluminescence Immunoassay (CLIA) Analyzers Market Report 2017, Trends, Analy …
According to Stratistics MRC, the Global Chemiluminescence Immunoassay (CLIA) Analyzers market is accounted for $4.12 billion in 2017 and is expected to reach $8.25 billion by 2026 growing at a CAGR of 8.0%. Increasing adoption of advanced technologies, rising incidences of chronic diseases demanding affordable care & advanced compassion and accuracy of Chemiluminescence immunoassay over enzyme are the factors driving the market growth. However, fragmented consumables market affecting profit margin
Chemiluminescence Immunoassay (CLIA) Analyzers Market: Global Industry growing a …
The report analyzes and presents an overview of ‘Chemiluminescence Immunoassay (CLIA) Analyzers - Global Market Outlook (2017-2026)' is a professional analysis, drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations and in-depth research & with a focus on the current state of the global industry. Global Chemiluminescence Immunoassay market is accounted for $4.53 billion in 2017 and is expected to reach $8.38 billion by 2026 growing at a CAGR of
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Insights & Future A …
Presently, the global chemiluminescence immunoassay (CLIA) analyzers market is regarded as an enhanced sensitivity as well as specificity of automated CLIA analyzers that hold the ability of multiplexing. It has been researched that, the market is primarily driven by growing demand for ultrasensitive diagnosis of disorders together with improved efficiency and precision, which is supported by innovations in the new run. For learning more about the CLIA analyzers market, a
Chemiluminescence Immunoassay (CLIA) Analyzers Market Study & Development Analys …
Global chemiluminescence immunoassay (CLIA) analyzers market is mainly driven by the rising demand for ultrasensitive diagnosis of disorders along with improved precision and efficiency, and increasing innovations in the new test offerings. The market is witnessing growing trend of introduction of novel tests with technologically advanced detection precision with reduced incubation time at affordable costs, which is anticipated to steer the global chemiluminescence immunoassay (CLIA) analyzers market growth. Request Sample Copy
Chemiluminescence Immunoassay (CLIA) Analyzers Market : Key Players, Growth, Ana …
Immunoassay is a bioanalytical method employed to determine or quantify the concentration of specific biomolecules in blood or other body fluids, which helps diagnose several types of diseases. Immunoassay methods are widely used in hospitals and diagnostic laboratories for diagnosis of diseases; in pharmaceutical and biotechnology industries to evaluate the therapeutic drug efficacy against several types of diseases; and in drug discovery and development studies. Immunoassays measure the concentration of